Las Vegas, NV -- (SBWIRE) -- 08/17/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Komatsu Ltd (ADR) (OTCMKTS:KMTUY), Arch Therapeutics Inc (OTCBB:ARTH), Invivo Therapeutics Holdings Corpp (OTCBB:NVIV), STELLAR BIOTECH INC (OTCMKTS:SBOTF)
Komatsu Ltd (ADR) (OTCMKTS:KMTU Y) declined -1.47%, trading on 41,819 shares, to end the trade at $22.78. The stock changed hands in a range of $22.72 to $22.90, bringing its market capitalization to about $21.17 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $18.73 and was moved to the maximum level of $29.63. Komatsu Ltd. engages in the development, manufacture, marketing, and sale of various industrial-use products and services under the Komatsu brand worldwide. Its Construction, Mining, and Utility Equipment segment offers excavating equipment, such as hydraulic and mini excavators, and backhoe loaders; loading equipment, including wheels and skid-steer loaders; grading and roadbed preparation equipment comprising bulldozers, motor graders, and vibratory rollers; hauling equipment consisting of off-highway and articulated dump trucks, and crawler carriers; and forestry equipment, such as harvesters, forwarders, and feller-bunchers.
Has KMTUY Found The Bottom and Ready To Move Up?Find Out Here
Arch Therapeutics Inc (OTCBB:ARTH) added 9.76%, to complete the trading session at $0.505, with a total volume of 1.39 million shares. The stock, on average, trades on a volume of 2.18 million shares. It floated in a range of $0.47 to $0.54. Its market capitalization now moved to about $22.22 million. In the past 52 weeks, the share price has not declined below $0.01 and above $1.36. Arch Therapeutics, Inc. (ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to provide a brief review of proposed future activities.
What was the Moving Force behind ARTH on Bullish Run? Read This Research Report
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) added 0.43% and was in a range of $4.05-$4.20 before closing at $4.20. The stock completed the day with a total volume of 158,762 shares, versus an average volume of 561,786 shares. The share price hit its 52-week low of $1.25 and $6.20 was the best price. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
For How Long NVIV will fight for Profitability? Read This Trend Analysis report
STELLAR BIOTECH INC (OTCMKTS:SBOTF) added 1.22% yesterday, bringing its market capitalization around $69.58 million. The share price, after opening at $1.33, made a high of $1.42 and hovered above $1.32 to end the day at $1.32. The total number of shares that changed hands during the session was448,572 shares, as compared to average trading volume of 229,622 shares.
For How Long SBOTF Gloss will Attract Investors? Find out via this report
About Value Stock Pick
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)